Typical GLP-1 medication criteria include BMI 30 or greater, or BMI 27 or greater with qualifying conditions
When used consistently, they result in: Decreased calorie intake Slower gastric emptying Improved insulin sensitivity Substantial weight loss For those with obesity or metabolic dysfunction, this is a medical breakthrough
A specialist can identify the true cause and create a plan to stabilize shedding and support regrowth.
Hematocrit, lipids, glucose tolerance, and liver enzymes warrant closest attention in dual therapy patients
GLP-1 Receptor Agonists Examples: Semaglutide Brand names: Ozempic , Wegovy Tirzepatide Brand names: Mounjaro , Zepbound When to stop: Weekly injections : Stop 7 days before surgery Daily doses : Skip the dose on the day of surgery The reason to stop GLP-1 drugs prior to surgery is that they cause delayed emptying of the stomach